Literature DB >> 21160734

Profound thrombocytopenia induced by clopidogrel with a prior history of long-term safe administration.

Yuan-Lin Guo1, Jian-Jun Li, Jin-Qing Yuan, Xue-Wen Qin, Xin Zheng, Chao-Wei Mu, Yi-Hong Hua.   

Abstract

Clopidogrel has shown an excellent safety, tolerability and efficacy ever since its marketing. However, here we report a rare case with profound thrombocytopenia following clopidogrel administration previously safely exposed to this same drug. This reminds us that thrombocytopenia might be induced by clopidogrel even with a prior, safe history of long-term administration.

Entities:  

Keywords:  Clopidogrel; Coronary artery disease; Stent; Thrombocytopenia

Year:  2010        PMID： 21160734      PMCID： PMC2999053          DOI： 10.4330/wjc.v2.i6.160

Source DB:  PubMed          Journal:  World J Cardiol


  13 in total

Review 1.  Acute profound thrombocytopenia following angioplasty: the dilemma in the management and a review of the literature.

Authors:  S N Makoni
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  Is there delayed restenosis in patients with coronary artery disease treated with sirolimus-eluting stent?

Authors:  Jian-Jun Li; Bo Xu; Yue-Jin Yang; Ji-Lin Chen; Shu-Bing Qiao; Wei-Hua Ma; Xue-Wen Qin; Min Yao; Hai-Bo Liu; Yong-Jian Wu; Jin-Qing Yuan; Jue Chen; Shi-Jie You; Jun Dai; Ran Xia; Run-Lin Gao
Journal:  Coron Artery Dis       Date:  2007-06       Impact factor: 1.439

Review 3.  Hematologic adverse effects of clopidogrel.

Authors:  Saravanan Balamuthusamy; Rohit Arora
Journal:  Am J Ther       Date:  2007 Jan-Feb       Impact factor: 2.688

4.  Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.

Authors:  Paul A Gurbel; Kevin P Bliden; Kathleen Butler; Mark J Antonino; Cheryl Wei; Renli Teng; Lars Rasmussen; Robert F Storey; Tonny Nielsen; John W Eikelboom; Georges Sabe-Affaki; Steen Husted; Dean J Kereiakes; David Henderson; Dharmendra V Patel; Udaya S Tantry
Journal:  Circulation       Date:  2010-03-01       Impact factor: 29.690

5.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

6.  [Clopidogrel and thrombopenia. A case report].

Authors:  G Helft; I Elalamy; C Laudy; D Tran; F Beygui; C Le Feuvre; F Ounissi; B Monnet de Lorbeau; C Khellaf; J P Metzger
Journal:  Ann Cardiol Angeiol (Paris)       Date:  2003-06

Review 7.  Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).

Authors:  Anaadriana Zakarija; Hau C Kwaan; Joel L Moake; Nicholas Bandarenko; Dilip K Pandey; June M McKoy; Paul R Yarnold; Dennis W Raisch; Jeffrey L Winters; Thomas J Raife; John F Cursio; Thanh Ha Luu; Elizabeth A Richey; Matthew J Fisher; Thomas L Ortel; Martin S Tallman; X Long Zheng; Masanori Matsumoto; Yoshihiro Fujimura; Charles L Bennett
Journal:  Kidney Int Suppl       Date:  2009-02       Impact factor: 10.545

8.  Clopidogrel-associated autoimmune thrombocytopenic purpura.

Authors:  Patricia J M Best; Verghese Mathew; Svetomir N Markovic
Journal:  Catheter Cardiovasc Interv       Date:  2004-07       Impact factor: 2.692

Review 9.  Clopidogrel desensitization: case report and review of published protocols.

Authors:  Phillip Owen; John Garner; Lawrence Hergott; Robert Lee Page
Journal:  Pharmacotherapy       Date:  2008-02       Impact factor: 4.705

10.  Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study.

Authors:  Yaling Han; Yi Li; Shouli Wang; Quanmin Jing; Zhulu Wang; Dongmei Wang; Qingfen Shu; Xiuying Tang
Journal:  Am Heart J       Date:  2009-03-17       Impact factor: 4.749
View more
  5 in total

1.  Severe thrombocytopenia following tirofiban infusion.

Authors:  Prashanth Panduranga; Kadhim Sulaiman
Journal:  Indian J Pharmacol       Date:  2011-11       Impact factor: 1.200

2.  Acute serious thrombocytopenia associated with intracoronary tirofiban use for primary angioplasty.

Authors:  Mustafa Yurtdaş; Yalin Tolga Yaylali; Nesim Aladağ; Mahmut Ozdemir; Memiş Hilmi Atay
Journal:  Case Rep Med       Date:  2014-03-10

3.  Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases.

Authors:  Salma Abdeladim; Mahassine Elharras; Amal Elouarradi; Ilham Bensahi; Sara Oualim; Fatimazahra Merzouk; Mohamed Sabry
Journal:  Pan Afr Med J       Date:  2021-01-05

4.  A rare case of eptifibatide-induced thrombocytopenia.

Authors:  Khalil Kamar; Kira MacDougall; Mira Alsheikh; Sara Parylo; Yevgeniy Skaradinskiy
Journal:  J Community Hosp Intern Med Perspect       Date:  2021-03-23

5.  Early profound secondary autoimmune thrombocytopenia induced by clopidogrel in a patient with a coronary artery stent.

Authors:  Volkan Karakuş; Burak Deveci; Erdal Kurtoğlu; Sakir Arslan
Journal:  Turk J Haematol       Date:  2012-03-05       Impact factor: 1.831
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.